Fig. 8.1 Dupuytren myofibroblasts. (a) Immunofluorescence staining of Dupuytren myofibroblasts in a 3D collagen matrix. Cell matrix junctions stained for integrin β1 (red), F actin (phalloidin) (green) and nuclei stained…
Fig. 12.1 From genotype to phenotype. Human genetic studies of Dupuytren Disease aim to identify the underlying genetic variation (genotype) contributing to the etiology of the disease (phenotype). The disease…
Fig. 2.1 The rate of surgery for Dupuytren contracture in the 143 NHS hospitals in England. The figure shows the different rates per 100,000 population, not standardised for age or…
© Springer International Publishing Switzerland 2017Paul M. N. Werker, Joseph Dias, Charles Eaton, Bert Reichert and Wolfgang Wach (eds.)Dupuytren Disease and Related Diseases – The Cutting Edge10.1007/978-3-319-32199-8_1 1. Treatment of Dupuytren Disease in Different Countries: A Welcome Address…
